» Articles » PMID: 10543283

Inflammatory Cell Populations and Cytokine MRNA Expression in the Nasal Mucosa in Aspirin-sensitive Rhinitis

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 1999 Oct 30
PMID 10543283
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Aspirin-sensitive rhinitis is characterized by severe perennial nasal congestion and discharge. The study questioned whether this disease, like immunoglobulin E-mediated rhinitis, might be associated with local recruitment and activation of T-lymphocytes, mast cells and eosinophils with parallel increases in "T-helper2-type" cytokines. Nasal biopsies from 10 patients with aspirin-sensitive rhinitis and 12 healthy controls subjects were studied. Nasal mucosal sections were examined by immunohistochemistry in order to determine cell phenotypes and by in situ hybridization to detect cells expressing messenger ribonucleic acid (mRNA) for cytokines. In aspirin-sensitive rhinitis there were increases in total (CD3+) (p=0.05) and activated (CD25+) T-cells (p=0.007), total (major basic protein (MBP) positive) (p=0.004) and activated (monoclonal antibody which recognizes the cleaved form of eosinophil cationic protein (EG2) positive) eosinophils (p=0.003), tryptase+ mast cells (p=0.04) and CD68+ macrophages (p=0.002). Neutrophils and cells expressing human leukocyte antigen-DR were no different. Marked increases were observed in the numbers of interleukin (IL)-5 mRNA+ cells (p=0.004) in aspirin-sensitive patients, whereas lower numbers of IL-4 mRNA+ cells were observed, with a trend for a difference from controls (p=0.07). No differences were observed for either IL-2 or interferon-gamma. In conclusion, in aspirin-sensitive rhinitis there is intense inflammation of the nasal mucosa characterised by T-lymphocytes, eosinophils and mast cells. The predominance of macrophages and disproportionate increase in interleukin-5 compared to interleukin-4 messenger ribonucleic acid expression suggests that factors other than "allergic" mechanisms may be important in this disease.

Citing Articles

Activation of the PGE-EP2 pathway as a potential drug target for treating eosinophilic rhinosinusitis.

Horikiri K, Taketomi Y, Kondo K, Yamasoba T, Murakami M Front Immunol. 2024; 15:1409458.

PMID: 39015572 PMC: 11250097. DOI: 10.3389/fimmu.2024.1409458.


-rs573790 Is Associated With Aspirin-Exacerbated Respiratory Disease: Replicative Study Using a Candidate Gene Strategy.

Pavon-Romero G, Perez-Rubio G, Ramirez-Jimenez F, Ambrocio-Ortiz E, Banuelos-Ortiz E, Alvarado-Franco N Front Genet. 2018; 9:363.

PMID: 30254660 PMC: 6141666. DOI: 10.3389/fgene.2018.00363.


Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease.

Kong S, Kim B, Uhm T, Chang H, Park J, Park S Exp Mol Med. 2016; 48(1):e202.

PMID: 27534531 PMC: 4686698. DOI: 10.1038/emm.2015.96.


Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances.

Steinke J, Wilson J J Asthma Allergy. 2016; 9:37-43.

PMID: 27022293 PMC: 4790533. DOI: 10.2147/JAA.S88739.


Hypersensitivity to Aspirin and other NSAIDs: Diagnostic Approach in Patients with Chronic Rhinosinusitis.

Makowska J, Lewandowska-Polak A, Kowalski M Curr Allergy Asthma Rep. 2015; 15(8):47.

PMID: 26149590 PMC: 4493793. DOI: 10.1007/s11882-015-0552-y.